|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 143.93 USD | -0.83% |
|
-3.37% | +17.26% |
| 03-06 | Gilead Sciences' HIV Drug Eyed for Local Production by South Africa | MT |
| 03-05 | The Year the Easy Narrative Broke |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 155.8 | 155.8 | 154.98 |
| Spread/Res. | -7.62% | -7.62% | -7.13% |
| Spread/Supp. | +3.14% | +12.38% | +18.85% |
| Support | 139.55 | 128.07 | 121.1 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- GILD Stock
- Charts Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition